#China #Shanghai #ESG Practices #WuXi AppTec #FTSE4Good

WuXi AppTec Secures Third Year on FTSE4Good Index

On August 5, 2025, WuXi AppTec, a key player in the pharmaceutical and life science industries, proudly announced its inclusion in the FTSE4Good Index Series for the third consecutive year. This prestigious acknowledgment highlights the company's ongoing commitment to sustainability and its efforts to foster a healthier world. Established by FTSE Russell, the FTSE4Good Index Series recognizes companies that exemplify robust Environmental, Social, and Governance (ESG) practices, and WuXi AppTec has proven its worth once again during the latest assessment cycle.

Achieving the highest score of 5 points in Corporate Governance, Anti-Corruption, and Labor Standards, WuXi AppTec's ecological and social performance underscores its dedication to sustainable management. Dr. Steve Yang, Co-CEO of WuXi AppTec and Chair of its ESG committee, expressed the company's pride in being recognized yet again. He stated, "This acknowledgment affirms the capital markets' confidence in WuXi AppTec's sustainable management practices. We remain committed to advancing our ESG initiatives while supporting our customers in bringing innovative new therapies to patients worldwide."

As an innovative partner in the pharmaceutical field, WuXi AppTec doesn’t just operate in a sustainable manner; it strategically integrates sustainability into its operations. Their influence is evident as they serve nearly 6,000 partners in over 30 countries, helping to bring groundbreaking treatments to those in need. The company has been acknowledged for its leadership in the ESG realm in various ways: a MSCI ESG Leadership Rating for five consecutive years, inclusion in the Dow Jones Sustainability Index for four years, and a commendation of A- in the CDP Climate Change assessment over three years.

WuXi AppTec has gone further with its sustainability commitments by attaining validation for its near-term emissions reduction targets from the Science Based Targets initiative (SBTi). Furthermore, the company is an active participant in the United Nations Global Compact, aligning its operations with ten principles that promote human rights, labor standards, environmental protection, and anti-corruption measures.

Additionally, as a recognized supplier partner to the Pharmaceutical Supply Chain Initiative (PSCI), WuXi AppTec showcases its engagement in fostering responsibly sourced materials and practices in the pharmaceutical supply chain. This solidifies the company’s stance as a pivotal contributor to not only advancing healthcare innovations but doing so with an ethical and social conscience that resonates throughout the industry.

In conclusion, WuXi AppTec's inclusion in the FTSE4Good Index for the third year in a row serves as a powerful testament to their commitment to sustainability and ethical practices in the pharmaceutical landscape. Their progress in ESG initiatives reflects a company that continues to lead by example, supporting the advancement of healthcare while prioritizing sustainable management practices across all operations.